Ontology highlight
ABSTRACT: Background
The interleukin-13 receptor alpha 2 (IL13RA2) and ephrin type A receptor 2 (EPHA2) are attractive therapeutic targets, being expressed in ~90% of canine and human gliomas, and absent in normal brain. Clinical trials using an earlier generation IL-13 based cytotoxin showed encouraging clinical effects in human glioma, but met with technical barriers associated with the convection-enhanced delivery (CED) method. In this study, IL-13 mutant and ephrin A1 (EFNA1)-based bacterial cytotoxins targeted to IL13RA2 and EPHA2 receptors, respectively, were administered locoregionally by CED to dogs with intracranial gliomas to evaluate their safety and preliminary efficacy.Methods
In this phase I, 3 + 3 dose escalation trial, cytotoxins were infused by CED in 17 dogs with gl
SUBMITTER: Rossmeisl JH
PROVIDER: S-EPMC7992889 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature